• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.14%

    Ocera Therapeutics, Inc. (OCRX)

    -NasdaqGM
    2.52 Up 0.06(2.44%) 9:30AM EDT - Nasdaq Real Time Price
    Prev Close:2.46
    Open:N/A
    Bid:0.01 x 300
    Ask:3.68 x 100
    1y Target Est:9.75
    Beta:2.57455
    Earnings Date:Aug 1 - Aug 5 (Est.)
    Day's Range:2.46 - 2.52
    52wk Range:2.00 - 4.80
    Volume:700
    Avg Vol (3m):85,256
    Market Cap:53.69M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OCRX

    Comparison

    Symbol% ChgMkt Cap
    OCRXUp 2.44%53.69M
    IRWDUp 0.73%1.80B
    THRXUp 0.41%1.15B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):388.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.39
    Quarterly EPS Est (Jun-16) :-0.35
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ocera Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the development and commercialization of OCR-002, which is in Phase IIb trials for the treatment of hyperammonemia and hepatic encephalopathy in patient... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback